Nektar Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NKTR and other ETFs, options, and stocks.

About NKTR

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit.

CEO

Howard W. Robin

CEOHoward W. Robin

Employees

Employees61

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1990

Founded1990

Employees

Employees61

NKTR Key Statistics

Market cap

431.66M

Market cap431.66M

Price-Earnings ratio

-2.80

Price-Earnings ratio-2.80

Dividend yield

—

Dividend yield—

Average volume

1.24M

Average volume1.24M

High today

$27.71

High today$27.71

Low today

$24.51

Low today$24.51

Open price

$26.62

Open price$26.62

Volume

1.10M

Volume1.10M

52 Week high

$37.38

52 Week high$37.38

52 Week low

$6.48

52 Week low$6.48

Analyst ratings

75%

of 8 ratings

Buy

75%

Hold

12.5%

Sell

12.5%

People also own

Based on the portfolios of people who own NKTR. This list is generated using Robinhood data, and it’s not a recommendation.